ArticleClinical neuroimaging (Hoboken, N.J.)2026
Differentiating Benign and Malignant Thyroglossal Duct Cysts With Ultrasonography, CT, and PET/CT.
Article in Clinical neuroimaging (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background Purpose: To determine if US, CT, and/or Methods: In this retrospective review, we identified 72 patients with cytologically proven benign TGDCs and 11 patients with cytologically proven malignant TGDCs. Patient demographics, US and CT features, and maximum standardized uptake value (SUVmax) on PET/CT were compared. On US, TGDCs were assigned a summary score with one point each for irregular margins, solid-component appearance, vascular flow on Doppler US, and calcifications. Score performance in differentiating benign and malignant TGDCs was analyzed. Results: Malignant TGDCs were detected at a younger age (optimal cut-off, 43.5 years) ( Conclusion: Malignant TGDCs are diagnosed at an earlier age, are larger, and have higher uptake on PET/CT than benign TGDCs. On US, cystic TGDCs or those containing only solid tissue with smooth margins may not need an FNA (fine needle aspiration) and may be followed with serial US. TGDCs with solid tissue with irregular margins, increased vascular flow, and calcifications are likely malignant; FNA before excision may be beneficial for documenting malignancy and genetic testing. All other TGDCs require FNA for differentiation. On PET/CT, TGDCs with increased uptake require FNA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.